关注
Ying Dai
Ying Dai
Harvard University, Beth Israel Deaconess Medical Center
在 bidmc.harvard.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Extra-nuclear estrogen receptor GPR30 regulates serotonin function in rat hypothalamus
H Xu, S Qin, GA Carrasco, Y Dai, EJ Filardo, ER Prossnitz, G Battaglia, ...
Neuroscience 158 (4), 1599-1607, 2009
1172009
Rapamycin drives selection against a pathogenic heteroplasmic mitochondrial DNA mutation
Y Dai, K Zheng, J Clark, RH Swerdlow, SM Pulst, JP Sutton, LA Shinobu, ...
Human molecular genetics 23 (3), 637-647, 2014
1002014
Pgc-1α overexpression downregulates Pitx3 and increases susceptibility to MPTP toxicity associated with decreased Bdnf
J Clark, JM Silvaggi, T Kiselak, K Zheng, EL Clore, Y Dai, CE Bass, ...
PloS one 7 (11), e48925, 2012
822012
Transglutaminase-catalyzed transamidation: a novel mechanism for Rac1 activation by 5-hydroxytryptamine2A receptor stimulation
Y Dai, NL Dudek, TB Patel, NA Muma
Journal of Pharmacology and Experimental Therapeutics 326 (1), 153-162, 2008
662008
线栓法大鼠局灶性脑缺血模型的改进
刘运泉, 戴颖
中国临床解剖学杂志 23 (002), 222-223, 2005
552005
Behavioral and metabolic characterization of heterozygous and homozygous POLG mutator mice
Y Dai, T Kiselak, J Clark, E Clore, K Zheng, A Cheng, GC Kujoth, ...
Mitochondrion 13 (4), 282-291, 2013
502013
Metabolomic analysis of exercise effects in the POLG mitochondrial DNA mutator mouse brain
J Clark-Matott, A Saleem, Y Dai, Y Shurubor, X Ma, A Safdar, MF Beal, ...
Neurobiology of aging 36 (11), 2972-2983, 2015
492015
Striatal expression of a calmodulin fragment improved motor function, weight loss, and neuropathology in the R6/2 mouse model of Huntington's disease
Y Dai, NL Dudek, Q Li, SC Fowler, NA Muma
Journal of Neuroscience 29 (37), 11550-11559, 2009
452009
Neuroprotective effects of calmodulin peptide 76‐121aa: disruption of calmodulin binding to mutant huntingtin
NL Dudek, Y Dai, NA Muma
Brain Pathology 20 (1), 176-189, 2010
382010
Fighting Alzheimer's disease and type 2 diabetes: pathological links and treatment strategies
Y Dai, M A Kamal
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014
352014
Phospholipase C, Ca2+, and calmodulin signaling are required for 5-HT2A receptor-mediated transamidation of Rac1 by transglutaminase
Y Dai, NL Dudek, Q Li, NA Muma
Psychopharmacology 213, 403-412, 2011
332011
Estradiol-induced desensitization of 5-HT1A receptor signaling in the paraventricular nucleus of the hypothalamus is independent of estrogen receptor-beta
DV Rossi, Y Dai, P Thomas, GA Carrasco, LL DonCarlos, NA Muma, Q Li
Psychoneuroendocrinology 35 (7), 1023-1033, 2010
332010
Protective effects of interrupting the binding of calmodulin to mutant huntingtin
NL Dudek, Y Dai, NA Muma
Journal of Neuropathology & Experimental Neurology 67 (4), 355-365, 2008
272008
Do Somatic Mitochondrial DNA Mutations Contribute to Parkinson′ s Disease?
J Clark, Y Dai, DK Simon
Parkinson’s disease 2011 (1), 659694, 2011
252011
Somatic mitochondrial DNA mutations do not increase neuronal vulnerability to MPTP in young POLG mutator mice
Y Dai, J Clark, K Zheng, GC Kujoth, TA Prolla, DK Simon
Neurotoxicology and teratology 46, 62-67, 2014
212014
Activation of the JAK-STAT pathway is necessary for desensitization of 5-HT2A receptor-stimulated phospholipase C signalling by olanzapine, clozapine and MDL …
RK Singh, Y Dai, JL Staudinger, NA Muma
International Journal of Neuropsychopharmacology 12 (5), 651-665, 2009
202009
针灸治疗脑梗塞的免疫调控机制
戴颖, 刘运泉, 宿宝贵
中华实用中西医杂志 16 (008), 1047-1048, 2003
52003
电针对脑缺血大鼠血清白细胞介素-6 的影响及其意义
戴颖, 刘运泉, 潘三强, 宿宝贵
中国临床康复 8 (19), 3816-3817, 2004
42004
电针对大鼠脑缺血区和血清 IL-6 表达的调节
戴颖, 刘运泉, 潘三强, 宿宝贵
中国临床解剖学杂志 22 (3), 297-300, 2004
42004
Based the Active Defense Substation Domain Strategy Control Method to against Blackout
QW Zhang, S Yang, Y Dai
Advanced Materials Research 1070, 687-692, 2015
2015
系统目前无法执行此操作,请稍后再试。
文章 1–20